{{Drugbox
| IUPAC_name               = 1-cyclopentyl-5-[(1''S'',9''R'')-4-hydroxy-1,10,13-trimethyl-10-azatricyclo[7.3.1.0<sup>2,7</sup>]trideca-2,4,6-trien-13-yl]-3-pentanone
| image                    = Quadazocine structure.svg
| CAS_number               = 69924-29-4
| ATC_prefix               = None
| ATC_suffix               = 
| PubChem                  = 115077
| ChemSpiderID             = 102983
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = X9BMD58553
| C = 25 | H = 37 | N = 1 | O = 2
| molecular_weight         = 383.567 g/mol
| smiles                   = O=C(CCC1CCCC1)CCC4([C@@H]3N(CC[C@]4(c2c(ccc(O)c2)C3)C)C)C
| StdInChI                 = 1S/C25H37NO2/c1-24-14-15-26(3)23(16-19-9-11-21(28)17-22(19)24)25(24,2)13-12-20(27)10-8-18-6-4-5-7-18/h9,11,17-18,23,28H,4-8,10,12-16H2,1-3H3/t23-,24+,25?/m1/s1
| StdInChIKey              = LOYWOYCPSWPKFH-CSIQULDISA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = 
| routes_of_administration = 
}}

'''Quadazocine''' ('''WIN-44,441''') is an [[opioid antagonist]] of the [[benzomorphan]] family which is used in [[scientific research]].<ref name="pmid6319882">{{cite journal |vauthors=Ward SJ, Pierson AK, Michne WF | title = Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist Win 44,441-3 | journal = Life Sciences | volume = 33 Suppl 1 | issue = | pages = 303–6 | year = 1983 | pmid = 6319882 | doi = 10.1016/0024-3205(83)90503-9| url = }}</ref> It acts as a [[silent antagonist]] at all three of the major [[opioid receptor]]s—[[μ-opioid receptor|μ]], [[κ-opioid receptor|κ]], and [[δ-opioid receptor|δ]],<ref name="pmid6319882" /><ref name="pmid16433932">{{cite journal |vauthors=Gharagozlou P, Hashemi E, DeLorey TM, Clark JD, Lameh J | title = Pharmacological profiles of opioid ligands at kappa opioid receptors | journal = BMC Pharmacology | volume = 6 | issue = | pages = 3 | year = 2006 | pmid = 16433932 | pmc = 1403760 | doi = 10.1186/1471-2210-6-3 | url = http://www.biomedcentral.com/1471-2210/6/3}}</ref> but with a significant preference in [[affinity (pharmacology)|affinity]] for the μ receptor and the κ<sub>2</sub> subtype.<ref name="Tseng1995">{{cite book | author = Leon F. Tseng | title = Pharmacology of Opioid Peptides | url = https://books.google.com/books?id=PhHTwIy9Wd8C&pg=PA238 | accessdate = 22 April 2012 | date = 1 September 1995 | publisher = CRC Press | isbn = 978-3-7186-5632-5 | page = 238}}</ref><ref name="RapakaSadée2008">{{cite book | author1 = Rao S. Rapaka | author2 = Wolfgang Sadée | title = Drug Addiction: From Basic Research to Therapy | url = https://books.google.com/books?id=Z36GjK1vABEC&pg=PA421 | accessdate = 22 April 2012 | date = 13 June 2008 | publisher = Springer | isbn = 978-0-387-76677-5 | page = 421}}</ref><ref name="pmid10093048">{{cite journal |vauthors=Zhang WM, Wu S, Yu XC, Wang HX, Bian JS, Wong TM | title = Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart | journal = Journal of Molecular and Cellular Cardiology | volume = 31 | issue = 2 | pages = 355–62 |date=February 1999 | pmid = 10093048 | doi = 10.1006/jmcc.1998.9998 | url = http://linkinghub.elsevier.com/retrieve/pii/S0022-2828(98)99998-9}}</ref> As such, it has been touted as a "κ<sub>2</sub>-selective" antagonist, though, of course, this is not entirely accurate on account of its similar affinity for the μ receptor.<ref name="Tseng1995" /><ref name="pmid10093048" /> As would be expected, quadazocine reverses the effects (e.g., [[analgesia]]) of [[opioid]] [[agonist]]s like [[morphine]] and [[fentanyl]] in animals.<ref name="pmid6319882" /><ref name="pmid14622776">{{cite journal |vauthors=Negus SS, Zuzga DS, Mello NK | title = Sex differences in opioid antinociception in rhesus monkeys: antagonism of fentanyl and U50,488 by quadazocine | journal = The Journal of Pain | volume = 3 | issue = 3 | pages = 218–26 |date=June 2002 | pmid = 14622776 | doi = 10.1054/jpai.2002.124734| url = http://linkinghub.elsevier.com/retrieve/pii/S1526590002000068}}</ref>

==See also==
* [[Dezocine]]

==References==
{{Reflist|2}}

{{Opioidergics}}

[[Category:Benzomorphans]]
[[Category:Opioid antagonists]]
[[Category:Kappa antagonists]]
[[Category:Cyclopentanes]]


{{nervous-system-drug-stub}}